Microbot Medical Inc. reported the exercise of 4,055,870 shares of common stock from August 26-27, 2025, generating approximately $8.6 million in gross proceeds. The exercise involved both Series H and Series I preferred investment options with prices of $2.10 and $2.13, respectively.